Leerink Partnrs Analysts Increase Earnings Estimates for A

Agilent Technologies, Inc. (NYSE:A - Free Report) - Investment analysts at Leerink Partnrs lifted their FY2025 earnings per share (EPS) estimates for shares of Agilent Technologies in a note issued to investors on Thursday, May 29th. Leerink Partnrs analyst P. Souda now expects that the medical research company will post earnings of $5.58 per share for the year, up from their previous forecast of $5.49. The consensus estimate for Agilent Technologies' current full-year earnings is $5.58 per share. Leerink Partnrs also issued estimates for Agilent Technologies' Q4 2025 earnings at $1.59 EPS, Q1 2026 earnings at $1.42 EPS, Q2 2026 earnings at $1.39 EPS, Q3 2026 earnings at $1.53 EPS, Q4 2026 earnings at $1.67 EPS, FY2026 earnings at $6.00 EPS and FY2027 earnings at $6.56 EPS.

Several other equities research analysts have also commented on the stock. Barclays cut their price target on shares of Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. JPMorgan Chase & Co. decreased their target price on Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating for the company in a research report on Thursday, May 29th. Leerink Partners raised their price target on Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research note on Friday. Jefferies Financial Group reduced their price objective on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating for the company in a research note on Monday, April 21st. Finally, UBS Group lowered their target price on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a research report on Thursday, May 29th. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $140.15.

Agilent Technologies Stock Up 1.5%

Shares of NYSE:A traded up $1.71 during trading on Monday, hitting $112.76. 1,490,647 shares of the company were exchanged, compared to its average volume of 2,092,285. The firm's 50 day moving average price is $108.27 and its 200-day moving average price is $126.27. Agilent Technologies has a 12-month low of $96.43 and a 12-month high of $153.84. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.60. The stock has a market capitalization of $32.15 billion, a P/E ratio of 27.84, a PEG ratio of 3.40 and a beta of 1.23.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.26 by $0.05. The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. The business's revenue for the quarter was up 6.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.22 EPS.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 23rd. Investors of record on Tuesday, July 1st will be issued a dividend of $0.248 per share. The ex-dividend date is Tuesday, July 1st. This represents a $0.99 annualized dividend and a yield of 0.88%. Agilent Technologies's dividend payout ratio is currently 24.44%.

Insiders Place Their Bets

In other Agilent Technologies news, Director Daniel K. Podolsky sold 1,819 shares of Agilent Technologies stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the transaction, the director now owns 35,737 shares in the company, valued at approximately $4,161,931.02. The trade was a 4.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Rodney Gonsalves sold 1,908 shares of the company's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the sale, the vice president now directly owns 21,786 shares in the company, valued at $2,657,456.28. This trade represents a 8.05% decrease in their position. The disclosure for this sale can be found here.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Global X Japan Co. Ltd. raised its stake in Agilent Technologies by 161.1% in the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock valued at $25,000 after purchasing an additional 116 shares during the last quarter. Redwood Park Advisors LLC acquired a new stake in shares of Agilent Technologies during the fourth quarter worth $27,000. Lee Danner & Bass Inc. purchased a new stake in shares of Agilent Technologies in the fourth quarter valued at $29,000. Sunbelt Securities Inc. increased its stake in Agilent Technologies by 640.0% in the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock valued at $30,000 after purchasing an additional 192 shares during the last quarter. Finally, Whipplewood Advisors LLC lifted its position in Agilent Technologies by 286.2% during the first quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock worth $29,000 after buying an additional 186 shares during the period.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.